@misc{10498/32774,
year = {2024},
month = {3},
url = {http://hdl.handle.net/10498/32774},
abstract = {Letter},
publisher = {Adis},
title = {Response to “Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis’”},
doi = {https://doi.org/10.1007/s13555-024-01106-2},
author = {Rand, K. and Ramos-Goñi, J. M. and Akmaz, B. and Solé-Feu, L. and Armario Hita, José Carlos},
}